Study for Teenagers with Alopecia Areata in Ontario

SID354 Website Image 1.png

Seeking Participants

  • Male or Female
  • Ages 12 - 18
  • Condition: Severe Alopecia Areata (Patchy Hair Loss)
SID354 Website Image 2.png

Study Details

Eternal Springtime Dermatology, an area leader in clinical research, is studying a potential treatment for teenagers with alopecia areata (patchy hair loss).

Study participants may receive the study treatment & study-related care from local doctors, and up to $1,000 compensation for their study-related time and travel.

Click the “Get Started” button to complete the sign up form. Then, we will see if this study is right for you.

How it works
Understanding the condition

What is Mild, Moderate, & Severe Alopecia Areata?

This research study is seeking adolescents with severe alopecia areata.

Mild Alopecia Areata

Small, well-defined bald patches, usually less than a few inches across, appearing on the scalp or beard. These spots are often subtle and may not be noticeable unless the hair is parted or closely inspected. Hair often regrows on its own or with simple treatments.

Moderate Alopecia Areata

Multiple or larger bald patches that may merge together, affecting a larger area of the scalp, eyebrows, beard, or body hair. Hair loss becomes more noticeable and persistent, often needing medical treatments like corticosteroid shots or topical therapies to stimulate regrowth.

Severe Alopecia Areata

Extensive hair loss that may cover most or all of the scalp (alopecia totalis) or progress to complete loss of body hair (alopecia universalis). Hair regrowth is unpredictable, and the emotional impact can be significant. Specialized treatments like oral immunosuppressants or advanced therapies are often needed to manage the condition.

How It Works

  1. Fill Out a Quick Form

    Enter a few details about yourself and your contact information.

  2. Complete Initial Questions Online

    Each study has unique requirements to participate.

  3. Call Our Team to Schedule Your Appointment

    If eligible to participate, book your screening appointment.

  4. Visit Our Office

    At your screening, our team will confirm whether you're all set to participate in this study.

Study Related Care

May receive study related care from medical professionals.

Compensation for Your Time​

May be compensated for participating in this clinical trial.

Contribute to Healthcare Advancement

Help pioneer new treatments for those who may be suffering from a similar condition.​

Your study team

Meet The Doctor

SID354 Website Image 4a.jpg

Dr. Anastasia Shamsuyarova

Dr. Anastasia Shamsuyarova is a double board-certified dermatologist in Canada and the U.S. She is the founder of Eternal Springtime Dermatology Clinic and serves at Thunder Bay Regional Hospital. She is also an Assistant Professor at NOSM.

Frequently Asked Questions

Do I need to pay anything throughout this process?

No, all study related costs may be covered.

What happens after I submit my form?

After you submit the contact form, your information will be sent to our team. You can then choose to complete your initial eligibility questions online. After completing your eligibility questions, if eligible, you’ll be in touch with our team to schedule your first in-person visit.

Do I get paid for participating in this study?

Yes, you may be compensated for your time and travel for study visits.

How do I know if I'm eligible to participate?

Each study has unique requirements to participate. You'll be able to answer initial eligibility questions online. Since some eligibility requirements can only be determined with a clinic visit, you will be sure of your full eligibility after your first visit.

Do you use my personal information for anything else?

No, our priority is keeping your personal information private and secure.

Eligibility check

Don't Worry. You are not committed to participate in a study by completing this form.

Answer a few questions about yourself and your eligibility. It only takes a couple of minutes.

Your answers go to the study team - nothing is shared publicly.